Paper1967157
Characterization of the breakpoint of a t(14;14)(q11.2;q32) from the leukemic cells of a patient with T-cell acute lymphoblastic leukemia.
Bertness VL and 6 others. Cancer Genet Cytogenet, 1990. Cited by 27 papers, by iCite.
Cite this record
ConductScience Library. Characterization of the breakpoint of a t(14;14)(q11.2;q32) from the leukemic cells of a patient with T-cell acute lymphoblastic leukemia. Papers, record 1967157. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1967157
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Characterization of the breakpoint of a t(14;14)(q11.2;q32) from the leukemic cells of a patient with T-cell acute lymphoblastic leukemia.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Chromosomes, Human, Pair 14 | Major topic |
| Leukemia-Lymphoma, Adult T-Cell | Major topic |
| Translocation, Genetic | Major topic |
| Amino Acid Sequence | |
| Animals | |
| Base Sequence | |
| Blotting, Southern | |
| Chromosome Banding | |
| Cloning, Molecular | |
| Cricetinae | |
| DNA Probes | |
| Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | |
| Humans | |
| Hybrid Cells | |
| Molecular Sequence Data | |
| Polymorphism, Restriction Fragment Length | |
| Restriction Mapping | |
| Tumor Cells, Cultured |
Source PubMed
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 27007892 | The complex translocation (9;14;14) involving IGH and CEBPE genes suggests a new subgroup in B-lineage acute lymphoblastic leukemia. | Genet Mol Biol | 2016 | https://conductscience.org/library/papers/27007892 | PubMed |
| 24966976 | T-cell lymphoblastic leukemia/lymphoma with t(7;14)(p15;q32) [TCRγ-TCL1A translocation]: a case report and a review of the literature. | Int J Clin Exp Pathol | 2014 | https://conductscience.org/library/papers/24966976 | PubMed |
| 23904235 | Breakpoint sites disclose the role of the V(D)J recombination machinery in the formation of T-cell receptor (TCR) and non-TCR associated aberrations in T-cell acute lymphoblastic leukemia. | Haematologica | 2013 | https://conductscience.org/library/papers/23904235 | PubMed |
| 11997518 | Essential role of AKT-1/protein kinase B alpha in PTEN-controlled tumorigenesis. | Mol Cell Biol | 2002 | https://conductscience.org/library/papers/11997518 | PubMed |
| 9742206 | Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation. | Biochem J | 1998 | https://conductscience.org/library/papers/9742206 | PubMed |
| 8415691 | Chromosome walking on the TCL1 locus involved in T-cell neoplasia. | Proc Natl Acad Sci U S A | 1993 | https://conductscience.org/library/papers/8415691 | PubMed |
| 7809072 | Identification of the TCL1 gene involved in T-cell malignancies. | Proc Natl Acad Sci U S A | 1994 | https://conductscience.org/library/papers/7809072 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| IGHD | 3495 | PubTator's text mining | https://conductscience.org/library/genes/3495 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1967157
GET https://conductscience.org/api/papers/v1/1967157/authors